Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:ZL0590 CAS:2230496-99-6 Purity:99.95% Package:1mg/RMB 828;5mg/RMB 1650;10mg/RMB 2480
|
Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
Tel: |
021-65675885 18964387627 |
Email: |
customer_service@efebio.com |
Products Intro: |
Product Name:ZL0590 CAS:2230496-99-6 Purity:99.00% Package:1mg;5mg;10mg
|
Company Name: |
RD International Technology Co., Limited
|
Tel: |
18024082417 |
Email: |
market@ubiochem.com |
Products Intro: |
Product Name:ZL0590 CAS:2230496-99-6 Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- manufacturers
- ZL0590
-
- $68.00 / 1mg
-
2024-11-19
- CAS:2230496-99-6
- Min. Order:
- Purity: 99.95%
- Supply Ability: 10g
|
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Basic information |
Product Name: | Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- | Synonyms: | Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]-;ZL0590;non-KAc binding site,ZL0590,ZL-0590,BRD4 BD1,Inhibitor,acute airway inflammation,inhibit,Epigenetic Reader Domain,ZL 0590;ZL0590, 10 mM in DMSO | CAS: | 2230496-99-6 | MF: | C23H27F3N4O4S | MW: | 512.55 | EINECS: | | Product Categories: | | Mol File: | 2230496-99-6.mol | |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Chemical Properties |
density | 1.411±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | 13.38±0.70(Predicted) | color | White to off-white |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Usage And Synthesis |
Biological Activity | ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor with an IC50 of 90 nM for human BRD4 BD1. ZL0590 exhibits significant anti-inflammatory activities[1]. | References | [1]. Liu Z, et al. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. J Med Chem. 2022;65(3):2388-2408. |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Preparation Products And Raw materials |
|